Works matching DE "EXENATIDE"

Results: 552

Comparison to Quality of Care in the UK vs Turkiye: A Case Report on an Elderly Patient with Type 2 Diabetes and Dementia.

Published in:

International Journal of Caring Sciences, 2025, v. 18, n. 1, p. 558

By:

Deniz, Bozkurt;
Elifnur, Gunes

Publication type:

Article

Effects of Exenatide plus Metformin versus Metformin alone on insulin resistance in women with Polycystic Ovary Syndrome: A systematic review and meta‐analysis.

Published in:

Journal of Obstetrics & Gynaecology Research, 2025, v. 51, n. 5, p. 1, doi. 10.1111/jog.16296

By:

Al‐Qudah, Abd‐alrahman;
Al‐Hanaktah, Mohammad;
Albadaineh, Reham

Publication type:

Article

Activation of GLP-1R modulates the spontaneous discharge of nigral dopaminergic neurons and motor behavior in mice with chronic MPTP Parkinson's disease.

Published in:

Frontiers in Aging Neuroscience, 2025, p. 1, doi. 10.3389/fnagi.2025.1529919

By:

Liu, Wen-Hong;
Liu, Cui;
Xue, Yan;
Sun, Xiang-Rong;
Chen, Xin-Yi;
Chen, Lei

Publication type:

Article

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

Published in:

Acta Diabetologica, 2021, v. 58, n. 5, p. 595, doi. 10.1007/s00592-020-01660-z

By:

Yang, Kun;
Wang, Haining;
Wei, Rui;
Xiao, Wenhua;
Tian, Qing;
Wang, Chen;
Yang, Jin;
Hong, Tianpei

Publication type:

Article

Efficacy of liraglutide on glycemic endpoints in people of Western European and South Asian descent with T2DM using multiple daily insulin injections: results of the MAGNA VICTORIA studies.

Published in:

Acta Diabetologica, 2021, v. 58, n. 4, p. 485, doi. 10.1007/s00592-020-01635-0

By:

Bizino, Maurice B.;
Jazet, Ingrid M.;
van Eyk, Huub J.;
Rensen, Patrick C. N.;
Geelhoed-Duijvestijn, Petronella H.;
Kharagjitsingh, Aan V.;
Paiman, Elisabeth H. M.;
Smit, Johannes W.;
Lamb, Hildebrandus J.

Publication type:

Article

Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Published in:

Acta Diabetologica, 2020, v. 57, n. 7, p. 809, doi. 10.1007/s00592-020-01487-8

By:

Rastogi, Ashu;
Dunbar, Richard L.;
Thacker, Hemant P.;
Bhatt, Jayesh;
Parmar, Krupi;
Parmar, Deven V.

Publication type:

Article

Subcutaneous nodules secondary to exenatide once weekly: clinical and histological findings.

Published in:

2016

By:

Donato, Sara;
Sargento, Dora;
Soares-de-Almeida, Luis;
Uva, Luis

Publication type:

Letter

Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes.

Published in:

Acta Diabetologica, 2015, v. 52, n. 6, p. 1083, doi. 10.1007/s00592-015-0792-2

By:

Li, Renyuan;
Xu, Wen;
Luo, Sihui;
Xu, Haixia;
Tong, Guoyu;
Zeng, Longyi;
Zhu, Dalong;
Weng, Jianping

Publication type:

Article

Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes.

Published in:

Acta Diabetologica, 2014, v. 51, n. 5, p. 865, doi. 10.1007/s00592-014-0638-3

By:

Bi, Yan;
Zhang, Bing;
Xu, Wen;
Yang, Huijie;
Feng, Wenhuan;
Li, Cuiliu;
Tong, Guoyu;
Li, Ming;
Wang, Xin;
Shen, Shanmei;
Zhu, Bin;
Weng, Jianping;
Zhu, Dalong

Publication type:

Article

Regression of diabetic macular edema after subcutaneous exenatide.

Published in:

2014

By:

Sarao, Valentina;
Veritti, Daniele;
Lanzetta, Paolo

Publication type:

Report

Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes.

Published in:

Acta Diabetologica, 2013, v. 50, n. 1, p. 39, doi. 10.1007/s00592-011-0319-4

By:

Gallwitz, Baptist;
Kazda, Christof;
Kraus, Petra;
Nicolay, Claudia;
Schernthaner, Guntram

Publication type:

Article

Involvement of Glucagon-Like Peptide-1 in the Regulation of Selective Excretion of Sodium or Chloride Ions by the Kidneys.

Published in:

Bulletin of Experimental Biology & Medicine, 2017, v. 162, n. 4, p. 436, doi. 10.1007/s10517-017-3634-0

By:

Marina, A.;
Kutina, A.;
Shakhmatoba, E.;
Natochin, Yu.

Publication type:

Article

Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study.

Published in:

Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 167, doi. 10.3906/sag-2004-154

By:

KÖSEOĞLU, Derya;
KOPARAL, Salih Suha;
BAŞER, Özden ÖZDEMİR;
BERKER, Dilek

Publication type:

Article

Efficacy of using oral methotrexate with phototherapy in the treatment of vitiligo in comparison with single phototherapy treatment: A double‐blinded randomized controlled trial.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2023, v. 39, n. 6, p. 657, doi. 10.1111/phpp.12918

By:

Lajevardi, Vahide;
Hosseini, Zahra Sadat Seyed;
Heidari, Sama

Publication type:

Article

The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Published in:

Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/8083417

By:

Wang, Jie;
Jin, Xinye;
An, Ping;
Yu, Songyan;
Mu, Yiming

Publication type:

Article

Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.

Published in:

Pediatric Diabetes, 2016, v. 17, n. 8, p. 545, doi. 10.1111/pedi.12337

By:

Bacha, Fida;
Klinepeter Bartz, Sara

Publication type:

Article

Exenatide for obesity in children and adolescents: Systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1290184

By:

Bin Chen;
Zhuan Zou;
Xiaoyan Zhang;
Dongqiong Xiao;
Xihong Li

Publication type:

Article

Emerging role of antidiabetic drugs in cardiorenal protection.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1349069

By:

Wen-Jia Fu;
Jin-Ling Huo;
Zi-Hui Mao;
Shao-Kang Pan;
Dong-Wei Liu;
Zhang-Suo Liu;
Peng Wu;
Zhong-Xiuzi Gao

Publication type:

Article

PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1088670

By:

Xu Liu;
Ling Song;
Yuanhui Zhang;
Haiyan Li;
Cheng Cui;
Dongyang Liu

Publication type:

Article

Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys.

Published in:

Psychopharmacology, 2019, v. 236, n. 2, p. 603, doi. 10.1007/s00213-018-5089-z

By:

Thomsen, Morgane;
Holst, Jens Juul;
Molander, Anna;
Linnet, Kristian;
Ptito, Maurice;
Fink-Jensen, Anders

Publication type:

Article

Effects of a Glucagon-like Peptide-1 Mimetic (Exenatide) in Healthy Cats.

Published in:

International Journal of Applied Research in Veterinary Medicine, 2012, v. 10, n. 2, p. 147

By:

Seyfert, Teresa M.;
Brunker, Jill D.;
Maxwell, Lara K.;
Payton, Mark E.;
McFarlane, Dianne

Publication type:

Article

Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus.

Published in:

Diabetes & Metabolism Journal, 2017, v. 41, n. 1, p. 69, doi. 10.4093/dmj.2017.41.1.69

By:

Kun-Ho Yoon;
Hardy, Elise;
Han, Jenny

Publication type:

Article

Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Published in:

Diabetes & Metabolism Journal, 2012, v. 36, n. 5, p. 364, doi. 10.4093/dmj.2012.36.5.364

By:

Juyoung Shin;
Jin-Sun Chang;
Hun-Sung Kim;
Sun-Hee Ko;
Bong-Yun Cha;
Ho-Young Son;
Kun-Ho Yoon;
Jae-Hyoung Cho

Publication type:

Article

Differences between patients initiating insulin and exenatide in clinical practice in Greece (the CHOICE study).

Published in:

Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes, 2012, v. 29, n. 3, p. 336

By:

Theodorakis, M. J.;
Aloumanis, K.;
Drossinos, E.

Publication type:

Article

Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes.

Published in:

Journal of Diabetes Investigation, 2014, v. 5, n. 5, p. 554, doi. 10.1111/jdi.12184

By:

Song, Sun Ok;
Kim, Kwang Joon;
Lee, Byung‐Wan;
Kang, Eun Seok;
Cha, Bong Soo;
Lee, Hyun Chul

Publication type:

Article

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus.

Published in:

Journal of Diabetes Investigation, 2013, v. 4, n. 2, p. 182, doi. 10.1111/jdi.12000

By:

Onishi, Yukiko;
Koshiyama, Hiroyuki;
Imaoka, Takeshi;
Haber, Harry;
Scism ‐ Bacon, Jamie;
Boardman, Marilyn K

Publication type:

Article

Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus.

Published in:

Journal of Diabetes Investigation, 2013, v. 4, n. 1, p. 53, doi. 10.1111/j.2040-1124.2012.00238.x

By:

Ji, Linong;
Onishi, Yukiko;
Ahn, Chul Woo;
Agarwal, Pankaj;
Chou, Chien‐Wen;
Haber, Harry;
Guerrettaz, Kelly;
Boardman, Marilyn K

Publication type:

Article

Weight loss associated with exenatide in an obese man with diabetes commenced on clozapine.

Published in:

2016

By:

Siskind, Dan;
Wysoczanski, Daniel;
Russell, Anthony;
Ashford, Mark

Publication type:

Case Study

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.

Published in:

PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290603

By:

Dankers, Marloes;
Verlegh, Peeter;
Weber, Karla;
Nelissen-Vrancken, Marjorie;
van Dijk, Liset;
Mantel-Teeuwisse, Aukje

Publication type:

Article

Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.

Published in:

Journal of Veterinary Internal Medicine, 2016, v. 30, n. 1, p. 92, doi. 10.1111/jvim.13817

By:

Riederer, A.;
Zini, E.;
Salesov, E.;
Fracassi, F.;
Padrutt, I.;
Macha, K.;
Stöckle, T.M.;
Lutz, T.A.;
Reusch, C.E.

Publication type:

Article

Exenatide and Sitagliptin Decrease Interleukin 1β, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis.

Published in:

2015

By:

Moraes, Renata M.;
Lima, Gabriela M. G.;
Oliveira, Felipe E.;
Brito, Ana Carolina V.;
Pereira, Rodrigo C.;
Oliveira, Luciane D.;
Barros, Patrícia P.;
Franco, Gilson C. N.;
Anbinder, Ana Lia

Publication type:

journal article

Drug release profile of a novel exenatide long-term drug delivery system (OKV-119) administered to cats.

Published in:

BMC Veterinary Research, 2024, v. 20, n. 1, p. 1, doi. 10.1186/s12917-024-04051-6

By:

Klotsman, Michael;
Anderson, Wayne H.;
Gilor, Chen

Publication type:

Article

Antiepileptic effects of exenatide in penicillin induced acute epilepsy model in rats.

Published in:

Indian Journal of Experimental Biology, 2023, v. 61, n. 6, p. 417, doi. 10.56042/ijeb.v61i06.1931

By:

Yildiz, Ayşegül;
Kocacan, Süleyman Emre;
Him, Aydın

Publication type:

Article

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study.

Published in:

2021

By:

Koska, Juraj;
Migrino, Raymond Q.;
Chan, Keith C.;
Cooper-Cox, Kelly;
Reaven, Peter D.

Publication type:

journal article

A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.

Published in:

2019

By:

Fayfman, Maya;
Galindo, Rodolfo J.;
Rubin, Daniel J.;
Mize, Dara L.;
Anzola, Isabel;
Urrutia, Maria A.;
Ramos, Clementina;
Pasquel, Francisco J.;
Haw, J. Sonya;
Vellanki, Priyathama;
Heqiong Wang;
Albury, Bonnie S.;
Weaver, Rita;
Cardona, Saumeth;
Umpierrez, Guillermo E.;
Wang, Heqiong

Publication type:

journal article

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.

Published in:

2018

By:

Jabbour, Serge A.;
Frías, Juan P.;
Hardy, Elise;
Hui Wang;
Öhman, Peter;
Ahmed, Azazuddin;
Guja, Cristian;
Wang, Hui

Publication type:

journal article

Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA<sub>1c</sub>: The FREEDOM-1 HBL (High Baseline) Study.

Published in:

2018

By:

Henry, Robert R.;
Rosenstock, Julio;
Denham, Douglas S.;
Prabhakar, Prakash;
Kjems, Lise;
Baron, Michelle A.

Publication type:

journal article

Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial.

Published in:

2018

By:

Rosenstock, Julio;
Buse, John B.;
Azeem, Rehan;
Prabhakar, Prakash;
Kjems, Lise;
Huang, Holly;
Baron, Michelle A.

Publication type:

journal article

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

Published in:

2018

By:

Ahmann, Andrew J.;
Capehorn, Matthew;
Charpentier, Guillaume;
Dotta, Francesco;
Henkel, Elena;
Lingvay, Ildiko;
Holst, Anders G.;
Annett, Miriam P.;
Aroda, Vanita R.

Publication type:

journal article

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes.

Published in:

2017

By:

Gourgari, Evgenia A.;
Mete, Mihriye;
Sampson, Maureen L.;
Harlan, David M.;
Remaley, Alan T.;
Rother, Kristina I.

Publication type:

Letter

Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study.

Published in:

2017

By:

Abdul-Ghani, Muhammad;
Migahid, Osama;
Megahed, Ayman;
Adams, John;
Triplitt, Curtis;
DeFronzo, Ralph A.;
Zirie, Mahmoud;
Jayyousi, Amin

Publication type:

journal article

Efficacy and Safety of Multiple Doses of Exenatide Once-Monthly Suspension in Patients With Type 2 Diabetes: A Phase II Randomized Clinical Trial.

Published in:

2016

By:

Wysham, Carol H.;
MacConell, Leigh;
Hardy, Elise

Publication type:

journal article

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.

Published in:

2016

By:

Smits, Mark M.;
Bunck, Mathijs C.;
Diamant, Michaela;
Corner, Anja;
Eliasson, Bjorn;
Heine, Robert J.;
Smith, Ulf;
Yki-Järvinen, Hannele;
van Raalte, Daniël H.

Publication type:

Letter

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666-670.

Published in:

2014

By:

Sarkar, Gayatri;
Alattar, May;
Brown, Rebecca J.;
Quon, Michael J.;
Harlan, David M.;
Rother, Kristina I.

Publication type:

Letter to the Editor

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666-670.

Published in:

2014

By:

Chaudhuri, Ajay;
Kuhadiya, Nitesh;
Ghanim, Husam;
Dandona, Paresh

Publication type:

Letter to the Editor

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes.

Published in:

Diabetes Care, 2014, v. 37, n. 9, p. 2451, doi. 10.2337/dc14-0398

By:

Gudipaty, Lalitha;
Rosenfeld, Nora K.;
Fuller, Carissa S.;
Gallop, Robert;
Schutta, Mark H.;
Rickels, Michael R.

Publication type:

Article

Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1).

Published in:

Diabetes Care, 2014, v. 37, n. 8, p. 2159, doi. 10.2337/dc13-2760

By:

Wysham, Carol;
Blevins, Thomas;
Arakaki, Richard;
Colon, Gildred;
Garcia, Pedro;
Atisso, Charles;
Kuhstoss, Debra;
Lakshmanan, Mark

Publication type:

Article

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes.

Published in:

Diabetes Care, 2014, v. 37, n. 3, p. 666, doi. 10.2337/dc13-1473

By:

Sarkar, Gayatri;
Alattar, May;
Brown, Rebecca J.;
Quon, Michael J.;
Harlan, David M.;
Rother, Kristina I.

Publication type:

Article

Erratum.

Published in:: 2014
Publication type:: Correction Notice

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin.

Published in:

Diabetes Care, 2013, v. 36, n. 10, p. 2945, doi. 10.2337/dc12-2709

By:

ROSENSTOCK, JULIO;
RACCAH, DENIS;
KORANYI, LASZLÓ;
MAFFEI, LAURA;
BOKA, GABOR;
MIOSSEC, PATRICK;
GERICH, JOHN E.

Publication type:

Article